Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VIEPAX XR 75MG TABLET - HSA Drug Approval Details

Approvals/HSA/VIEPAX XR 75MG TABLET

Approved

THERAPEUTIC

VIEPAX XR 75MG TABLET

DEXCEL LTD (ISRAEL)🇸🇬 Health Sciences Authority

Approval Date: Jun 19, 2008
Approval ID: 28784313deacb5a2
Company: DEXCEL LTD (ISRAEL)
Type: Therapeutic

Approval Details

Approval Id: 28784313deacb5a2
Drug Name: VIEPAX XR 75MG TABLET
Product Name: VIEPAX XR 75MG TABLET
Approval Number: SIN13478P
Approval Date: 2008-06-19
Registrant: APEX PHARMA MARKETING PTE. LTD.
Licence Holder: APEX PHARMA MARKETING PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET, EXTENDED RELEASE
Route Of Administration: ORAL
Atc Code: N06AX16
Atc Item Name: venlafaxine
Pharma Manufacturer Name: APEX PHARMA MARKETING PTE. LTD.

Active Ingredients

VENLAFAXINE HYDROCHLORIDE 84.85 mg EQV VENLAFAXINE

75 mg

VENLAFAXINE HYDROCHLORIDE 84.85 MG EQV VENLAFAXINE

75 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 19, 2008

Approval ID

28784313deacb5a2

Type

Therapeutic

Back to HSA Approvals